Hetero Labs Gets CDSCO Panel Nod To Study Antibiotic Tebipenem Pivoxil Dispersible Tablet Dr. Divya Colin17 July 2023 6:00 PM ISTNew Delhi: Stating that the decision to waive off the clinical trial will be taken after a review of the Bioequivalence study report, the Subject...
Conduct bioequivalence Study of Elagolix tablets: CDSCO panel tells Hetero Labs Dr. Divya Colin16 July 2023 5:30 PM ISTNew Delhi: In response to the proposal presented by the drug major Hetero Labs to manufacture and market Elagolix tablet 150mg and 200mg, the Subject...
Hetero, Sun Pharma recall products in US over manufacturing issues Ruchika Sharma24 April 2023 12:15 PM ISTHetero USA Inc is recalling 2,352 bottles of Pantoprazole Sodium delayed release tablets for "CGMP Deviations: Discoloration", the USFDA stated.
Hetero Group to invest Rs 1000 crore to expand pharma, specialist business in Andhra Pradesh Ruchika Sharma4 March 2023 3:46 PM ISTAndhra Pradesh: Drug maker Hetero Group will be investing Rs 1,000 crore to expand its pharmaceutical and specialist business in Andhra Pradesh, its...
Hetero Biopharma gets CDSCO panel nod to market, manufacture Tenecteplase Susmita Roy29 Dec 2022 5:43 PM ISTNew Delhi: Pharma major Hetero Biopharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
FIRST: Hetero wins WHO Prequalification for generic version of Pfizer COVID drug Paxlovid Ruchika Sharma26 Dec 2022 4:15 PM ISTThe combi pack, launched by Hetero as NIRMACOM, will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet).
JnJ sells Telangana plant to Hetero for Rs 130 crore Ruchika Sharma18 Oct 2022 1:30 PM ISTThe facility will be Hetero's flagship sterile pharmaceutical and biologics manufacturing unit and will generate 2,000 new jobs, Hetero said in a...
Hetero unveils new logo, corporate brand identity Ruchika Sharma12 May 2022 11:15 AM ISTThe new logo is effective immediately and will be implemented across the Group's companies, solutions, assets, services, and products in due course,...
Hetero COVID drug Molnupiravir shows positive results in Phase III trials Ruchika Sharma21 Feb 2022 4:37 PM ISTHyderabad: Hetero, a globally renowned vertically integrated pharmaceutical organization has recently announced the positive results of Phase III...
Hetero Labs, Optimus proposal to launch generic Paxlovid rejected by CDSCO panel: Report Dr. Divya Colin27 Jan 2022 6:10 PM ISTNew Delhi: In a major setback to Hetero Labs and Optimus Pharma, Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Raid on Hetero Pharma Group: IT Dept detects Rs 550 crore hidden income, seizes Rs 142 crore cash Medical Dialogues Team10 Oct 2021 10:30 AM ISTNew Delhi: The Income Tax Department detected "unaccounted" income of Rs 550 crore and seized over Rs 142 crore cash after it recently raided...
Hetero gets DCGI emergency use approval for Tocilizumab biosimilar for Covid-19 Ruchika Sharma6 Sept 2021 3:36 PM ISTNew Delhi: Drug firm Hetero on Monday said it has received emergency use authorisation from Drug Controller General of India (DCGI) for its biosimilar...
